University of New South Wales, Australia;Dr Donel Martin is a Clinical Academic Researcher based at the Black Dog Institute and University of New South Wales and practicing Senior Clinical Neuropsychologist. He has a Ph.D in psychology and a Master’s in clinical neuropsychology. He is the Head of the Neurocognition team at the Black Dog Institute, which investigates the cognitive and emotional effects of interventional treatments for psychiatric disorders, including ketamine, psilocybin, non-invasive brain stimulation and ECT. He has been a researcher for over 18 years and published >150 peer-review papers and 14 book chapters and has been cited over 5000 times. In the field of psychiatry/psychology he is in the top 1% of highly cited authors.

University of Zurich, Switzerland;Alexander Tarnutzer graduated from medical school in 2003. In 2004 he took a position as a Research Fellow in the Vestibulo-ocular Motor Laboratory of Prof. D. Straumann (Zurich, Switzerland) and started neurology residency (University Hospital Zurich). In 2009 he joined the Vestibular/Eye Movement Testing Laboratory (Prof. D.S. Zee) at the Johns Hopkins University School of Medicine (Baltimore, USA) for one year. He became a board-certified Neurologist in 2012 and continued to work clinically and as a Research Fellow in Prof. Straumann’s laboratory. He received his habilitation in 2014. In 2018 he was appointed Head of Neurology/Stroke Unit at the Cantonal Hospital of Baden, Switzerland. In 2021 he became a titular Professor in neurology. His main research interests include bedside diagnostic accuracy in acutely dizzy patients, pattern recognition in vestibular disorders, the management of vestibular deficits after traumatic brain injury and harmonizing ocular motor/vestibular testing in hereditary ataxia.